maintenance on semaglutide dose every other week 🚨 Diabetes Guidelines Update 2026

Dan McKees proposed fiscal year 2027 budget would remove GLP-1 drugs from Rhode Islands Medicaid formulary for weight loss, saving $6.3 million in general revenue

The Grand Rapids-based chain announced Tuesday it is making Wegovy and Ozempic more affordable to customers by accepting savings programs available with NovoCare.

Contemporary recommendations advise very low targets for patients at highest risk.

Blue Cross and Blue Shield of Texas has indicated today that they will provide consumers the option this upcoming fall to rewrite their current plan as is, and be able to keep that plan until December 2014

Diabetic Gastroparesis Market Size was valued at USD 1,970 million in 2023, growing at a significant CAGR during the Forecast Period from 2024 to 2034.